{
    "SPADE_N_14080": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14080",
            "Peptide Name": "Lan-P49.2 (natural AMPs; nisin-like, lantibiotic, type 1, class 1 bacteriocin, Gram-positive bacteria, prokaryotes; UCSS1b; more AMPs?)",
            "Source": "Pseudobutyrivibrio sp. 49_2",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "ITSKSLCTPGCVTGVLMGCNNKTATCNCSVHVG",
            "Sequence Length": 33,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3299.86,
            "PI": 8.43,
            "Hydrophobicity": 0.44,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Zhang ZJ, Wu C, Moreira R, Dorantes D, Pappas T, Sundararajan A, Lin H, Pamer EG, van der Donk WA.2024",
                    "Reference": "ACS Chem Biol. 2024 Jan 31. doi: 10.1021/acschembio.3c00577.PubMed",
                    "Title": "Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals."
                }
            ],
            "Frequent Amino Acids": "CTG",
            "Absent Amino Acids": "DEFOQRUWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 24,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Net Charge": 3,
            "Comments": "Discovery: applied RODEO to the public RefSeq database to identify novel nisin-like class I lantibiotics encoded in gut microbial genomes.Sequence analysis: APD analysis reveals that this sequence is similar (85.29%) toNisin QActivity:  Active against E. faecium ATCC700221 (MIC 10-100 uM), Methicillin-resistant S. aureus USA300 MRSA (MIC 10-100 uM), Methicillin-resistant S. epidermidis SK135 (MIC 10-100 uM), L. monocytogenes 10403S (MIC 10-100 uM), and C. difficile VPI10463 (MIC 1-10 uM), A. hadrus MSK.14.23 (MIC 0.01 uM), B. obeum MSK.18.40 (MIC 0.1 uM), B. luti MSK.20.18 (MIC 0.1 uM), E. ramosum MSK.23.96 (MIC 10 uM), D. formicogenerans MSK.17.61 (MIC 0.01-0.1 uM), C. comes MSK.11.23 (MIC 0.01 uM), C. eutactus MSK.18.32 (MIC 0.1-1 uM), and F. fissicatena MSK.9.3 (MIC 0.1 uM).Recombinant production:bacteria:Escherichia coli: expressed in E. coli followed by isolation and purification. Est.2024; 4/2024",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15415",
                    "Similarity": 0.9,
                    "Sequence": "ISKLCTPGCVTGVLMGCNNKTATCNCVHVG"
                },
                {
                    "SPADE_ID": "SPADE_N_00045",
                    "Similarity": 0.8787878787878788,
                    "Sequence": "ITSISLCTPGCKTGVLMGCNLKTATCNCSVHVSK"
                },
                {
                    "SPADE_ID": "SPADE_N_06115",
                    "Similarity": 0.8787878787878788,
                    "Sequence": "MSTKDFNLDLVSVSKTDSGASTRITSISLCTPGCKTGVLMGCNLKTATCNCSVHVSK"
                }
            ]
        }
    }
}